secwatch.observer — SEC 8-K summary
======================================

Issuer:     Emergent BioSolutions Inc. (EBS)
CIK:        0001367644
Form:       8-K
Filed at:   2023-10-02T23:59:59+00:00
Accession:  0001367644-23-000166
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Emergent BioSolutions appoints DeGolyer and Fowler to board, adopts inducement plan
--------------------------------------------------------------------------------

- Donald DeGolyer and Neal Fowler appointed Class III directors effective Oct 1, 2023; terms expire at 2024 annual meeting.
- Both are independent; DeGolyer on Compensation Committee, Fowler on Audit and Finance Committee.
- Each receives initial RSU grant valued at $375,000, vesting in three equal annual installments.
- Board adopted Inducement Plan reserving 5 million shares for equity grants to new hires.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367644/000136764423000166/0001367644-23-000166-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367644/000136764423000166/ebs-20230928.htm
  HTML page:      https://secwatch.observer/filing/0001367644-23-000166

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer